CLB

CLB
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $134.521M ▲ | $5.098M ▼ | $14.239M ▲ | 10.585% ▲ | $0.3 ▲ | $24.522M ▲ |
| Q2-2025 | $130.159M ▲ | $7.497M ▼ | $10.636M ▲ | 8.172% ▲ | $0.22 ▲ | $22.645M ▲ |
| Q1-2025 | $123.585M ▼ | $15.982M ▲ | $-154K ▼ | -0.125% ▼ | $-0.003 ▼ | $8.097M ▼ |
| Q4-2024 | $129.237M ▼ | $5.2M ▲ | $7.403M ▼ | 5.728% ▼ | $0.16 ▼ | $17.838M ▼ |
| Q3-2024 | $134.397M | $4.113M | $11.745M | 8.739% | $0.25 | $23.479M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $25.629M ▼ | $591.36M ▼ | $313.972M ▼ | $271.347M ▲ |
| Q2-2025 | $31.188M ▲ | $602.111M ▲ | $334.808M ▲ | $261.283M ▲ |
| Q1-2025 | $22.107M ▲ | $591.519M ▲ | $332.163M ▼ | $253.388M ▲ |
| Q4-2024 | $19.157M ▼ | $590.406M ▼ | $332.669M ▼ | $251.991M ▲ |
| Q3-2024 | $21.474M | $600.466M | $344.045M | $250.742M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $14.524M ▲ | $8.502M ▼ | $2.393M ▲ | $-16.454M ▼ | $-5.559M ▼ | $5.47M ▼ |
| Q2-2025 | $10.636M ▲ | $14.717M ▲ | $-1.678M ▼ | $-3.494M ▲ | $9.081M ▲ | $10.084M ▲ |
| Q1-2025 | $69K ▼ | $6.66M ▼ | $772K ▲ | $-4.482M ▲ | $2.95M ▲ | $3.081M ▼ |
| Q4-2024 | $7.469M ▼ | $20.615M ▲ | $-3.559M ▼ | $-19.373M ▼ | $-2.317M ▼ | $16.234M ▲ |
| Q3-2024 | $11.745M | $13.097M | $-491K | $-8.827M | $3.779M | $10.371M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
Product | $70.00M ▲ | $30.00M ▼ | $30.00M ▲ | $30.00M ▲ |
Service | $190.00M ▲ | $100.00M ▼ | $100.00M ▲ | $100.00M ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Core Laboratories today looks like a more financially stable, cash-generative niche specialist than it was in the early pandemic period. Earnings and margins have recovered but remain modest and tied to oil and gas activity levels. The balance sheet has been repaired, with lower debt and rebuilt equity, supported by steady free cash flow and relatively light capital needs. Competitively, the company benefits from decades of data, specialized expertise, and proprietary technologies that are not easy to copy. Its push into digital tools and energy-transition applications (such as carbon storage and geothermal) offers potential new growth avenues, but success will depend on how quickly these markets develop and how well management executes the shift while still navigating the usual ups and downs of the oil and gas cycle.
NEWS
October 22, 2025 · 5:00 PM UTC
CORE LAB REPORTS THIRD QUARTER 2025 RESULTS
Read more
September 30, 2025 · 4:15 PM UTC
CORE LABORATORIES ANNOUNCES STRATEGIC ACQUISITION OF BRAZIL-BASED SOLINTEC
Read more
September 24, 2025 · 4:30 PM UTC
CORE LABORATORIES ANNOUNCES TIMING OF THIRD QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL
Read more
About Core Laboratories N.V.
https://www.corelab.comCore Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $134.521M ▲ | $5.098M ▼ | $14.239M ▲ | 10.585% ▲ | $0.3 ▲ | $24.522M ▲ |
| Q2-2025 | $130.159M ▲ | $7.497M ▼ | $10.636M ▲ | 8.172% ▲ | $0.22 ▲ | $22.645M ▲ |
| Q1-2025 | $123.585M ▼ | $15.982M ▲ | $-154K ▼ | -0.125% ▼ | $-0.003 ▼ | $8.097M ▼ |
| Q4-2024 | $129.237M ▼ | $5.2M ▲ | $7.403M ▼ | 5.728% ▼ | $0.16 ▼ | $17.838M ▼ |
| Q3-2024 | $134.397M | $4.113M | $11.745M | 8.739% | $0.25 | $23.479M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $25.629M ▼ | $591.36M ▼ | $313.972M ▼ | $271.347M ▲ |
| Q2-2025 | $31.188M ▲ | $602.111M ▲ | $334.808M ▲ | $261.283M ▲ |
| Q1-2025 | $22.107M ▲ | $591.519M ▲ | $332.163M ▼ | $253.388M ▲ |
| Q4-2024 | $19.157M ▼ | $590.406M ▼ | $332.669M ▼ | $251.991M ▲ |
| Q3-2024 | $21.474M | $600.466M | $344.045M | $250.742M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $14.524M ▲ | $8.502M ▼ | $2.393M ▲ | $-16.454M ▼ | $-5.559M ▼ | $5.47M ▼ |
| Q2-2025 | $10.636M ▲ | $14.717M ▲ | $-1.678M ▼ | $-3.494M ▲ | $9.081M ▲ | $10.084M ▲ |
| Q1-2025 | $69K ▼ | $6.66M ▼ | $772K ▲ | $-4.482M ▲ | $2.95M ▲ | $3.081M ▼ |
| Q4-2024 | $7.469M ▼ | $20.615M ▲ | $-3.559M ▼ | $-19.373M ▼ | $-2.317M ▼ | $16.234M ▲ |
| Q3-2024 | $11.745M | $13.097M | $-491K | $-8.827M | $3.779M | $10.371M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
Product | $70.00M ▲ | $30.00M ▼ | $30.00M ▲ | $30.00M ▲ |
Service | $190.00M ▲ | $100.00M ▼ | $100.00M ▲ | $100.00M ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Core Laboratories today looks like a more financially stable, cash-generative niche specialist than it was in the early pandemic period. Earnings and margins have recovered but remain modest and tied to oil and gas activity levels. The balance sheet has been repaired, with lower debt and rebuilt equity, supported by steady free cash flow and relatively light capital needs. Competitively, the company benefits from decades of data, specialized expertise, and proprietary technologies that are not easy to copy. Its push into digital tools and energy-transition applications (such as carbon storage and geothermal) offers potential new growth avenues, but success will depend on how quickly these markets develop and how well management executes the shift while still navigating the usual ups and downs of the oil and gas cycle.
NEWS
October 22, 2025 · 5:00 PM UTC
CORE LAB REPORTS THIRD QUARTER 2025 RESULTS
Read more
September 30, 2025 · 4:15 PM UTC
CORE LABORATORIES ANNOUNCES STRATEGIC ACQUISITION OF BRAZIL-BASED SOLINTEC
Read more
September 24, 2025 · 4:30 PM UTC
CORE LABORATORIES ANNOUNCES TIMING OF THIRD QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL
Read more

CEO
Lawrence V. Bruno
Compensation Summary
(Year 2015)

CEO
Lawrence V. Bruno
Compensation Summary
(Year 2015)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2010-07-09 | Forward | 2:1 |
| 1997-12-22 | Forward | 2:1 |
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
Grade Summary
Price Target
Institutional Ownership

ARIEL INVESTMENTS, LLC
13.774M Shares
$207.981M

BLACKROCK INC.
7.798M Shares
$117.75M

BLACKROCK, INC.
7.258M Shares
$109.594M

DISCIPLINED GROWTH INVESTORS INC /MN
5.97M Shares
$90.145M

EARNEST PARTNERS LLC
3.428M Shares
$51.758M

VANGUARD GROUP INC
3.047M Shares
$46.016M

STATE STREET CORP
1.977M Shares
$29.851M

DIMENSIONAL FUND ADVISORS LP
1.111M Shares
$16.777M

GEODE CAPITAL MANAGEMENT, LLC
1.106M Shares
$16.707M

T. ROWE PRICE INVESTMENT MANAGEMENT, INC.
908.158K Shares
$13.713M

BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
893.642K Shares
$13.494M

EMERALD ACQUISITION LTD.
846.103K Shares
$12.776M

FISHER ASSET MANAGEMENT, LLC
824.579K Shares
$12.451M

RUSSELL FRANK CO/
794.999K Shares
$12.004M

CHARLES SCHWAB INVESTMENT MANAGEMENT INC
657.243K Shares
$9.924M

NORTHERN TRUST CORP
577.733K Shares
$8.724M

GENDELL JEFFREY L
569.471K Shares
$8.599M

HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC
559.625K Shares
$8.45M

MORGAN STANLEY
504.194K Shares
$7.613M

ROYCE & ASSOCIATES LP
440.442K Shares
$6.651M
Summary
Only Showing The Top 20



